These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23735299)

  • 1. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
    Vázquez-Calvo Á; Martín-Acebes MA; Sáiz JC; Ngo N; Sobrino F; de la Torre JC
    Antiviral Res; 2013 Aug; 99(2):172-9. PubMed ID: 23735299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
    Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
    Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
    J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
    Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers.
    Lee AM; Rojek JM; Gundersen A; Ströher U; Juteau JM; Vaillant A; Kunz S
    Virology; 2008 Mar; 372(1):107-17. PubMed ID: 18022208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.
    Byford O; Shaw AB; Tse HN; Todd EJAA; Álvarez-Rodríguez B; Hewson R; Fontana J; Barr JN
    J Virol; 2024 Mar; 98(3):e0200623. PubMed ID: 38334330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K/Akt pathway contributes to arenavirus budding.
    Urata S; Ngo N; de la Torre JC
    J Virol; 2012 Apr; 86(8):4578-85. PubMed ID: 22345463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.
    Kim YJ; Cubitt B; Chen E; Hull MV; Chatterjee AK; Cai Y; Kuhn JH; de la Torre JC
    Antiviral Res; 2019 Sep; 169():104558. PubMed ID: 31302150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.
    Sánchez AB; Perez M; Cornu T; de la Torre JC
    J Virol; 2005 Sep; 79(17):11071-81. PubMed ID: 16103158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of enveloped virus infection of cultured cells by valproic acid.
    Vázquez-Calvo A; Saiz JC; Sobrino F; Martín-Acebes MA
    J Virol; 2011 Feb; 85(3):1267-74. PubMed ID: 21106740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.
    Martínez-Sobrido L; Zúñiga EI; Rosario D; García-Sastre A; de la Torre JC
    J Virol; 2006 Sep; 80(18):9192-9. PubMed ID: 16940530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells expressing the RING finger Z protein are resistant to arenavirus infection.
    Cornu TI; Feldmann H; de la Torre JC
    J Virol; 2004 Mar; 78(6):2979-83. PubMed ID: 14990716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage.
    Welsh RM; Seedhom MO
    Curr Protoc Microbiol; 2008 Feb; Chapter 15():Unit 15A.1. PubMed ID: 18770534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    de la Torre JC
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
    Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of viral infectivity through lethal defection.
    Grande-Pérez A; Lázaro E; Lowenstein P; Domingo E; Manrubia SC
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4448-52. PubMed ID: 15767582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies.
    Emonet SE; Urata S; de la Torre JC
    Virology; 2011 Mar; 411(2):416-25. PubMed ID: 21324503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.